FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine. Described is a haemostatic composite structure, which has a biologically absorbable woven or non-woven substrate, which has at least two main opposite areas of the surface and an integral non-porous polymer film, applied on one basic surface of the said substrate. The biologically absorbable woven substrate can consist of an oxidised polysaccharide, and the non-woven substrate can consist of biologically absorbable non-cellulose derivatives of polymers. The integral non-porous polymer film can consist of a biologically absorbable polymer. Described is a method of providing haemostasis by the application of the composite structure.
EFFECT: composite structure provides effective haemostasis, ie makes it possible to reduce the time for attaining haemostasis.
14 cl, 4 tbl, 8 ex, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| REINFORCED RESORBABLE SYNTHETIC MATRIX FOR HAEMOSTATIC APPLICATIONS | 2011 |
|
RU2574016C2 |
| HEMOSTATIC POWDERS OF OXIDED REGENERATED CELLULOSE AND METHODS OF THEIR PRODUCTION | 2013 |
|
RU2629199C2 |
| HAEMOSTATIC POWDERS OF OXIDISED REGENERATED CELLULOSE AND METHODS FOR PRODUCTION THEREOF | 2013 |
|
RU2696575C2 |
| HEMOSTATIC COMPOSITIONS AND METHODS FOR THEIR PREPARATION | 2017 |
|
RU2756891C2 |
| SHEET MOULDING AND HAEMOSTATIC MATERIAL | 2013 |
|
RU2669569C2 |
| HEMOSTATIC BIOLOGICALLY ABSORBABLE DEVICE WITH POLYETHYLENE GLYCOL AS A BINDING SUBSTANCE | 2012 |
|
RU2646728C1 |
| METHOD FOR MAKING BANDAGE | 2007 |
|
RU2444375C2 |
| HEMOSTATIC BIOLOGICALLY ABSORBED DEVICE WITH POLYETHYLENE GLYCOL AS BINDING SUBSTANCE | 2012 |
|
RU2627426C2 |
| COMPACTED HAEMOSTATIC CELLULOSE AGGREGATES | 2016 |
|
RU2702339C1 |
| COMPACT HEMOSTATIC CELLULOSE UNITS | 2016 |
|
RU2767670C2 |
